NCT00441987View on ClinicalTrials.gov

Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953

PHASE1CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Healthy
Interventions
DRUG

GSI-953

Trial Locations (1)

141-0001

Kitashinagawa

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00441987 - Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953 | Biotech Hunter | Biotech Hunter